CSTONE PHARMA-B (02616) Grants 15.7155 Million Share Options and 8.055 Million Restricted Share Units

Stock News
01/23

On January 23, 2026, the Board of Directors resolved to grant a total of 15.7155 million share options to 96 grantees under the Post-IPO Employee Share Option Scheme. Among the total of 15.7155 million share options granted, 7 million were awarded to one director, with the remaining 8.7155 million granted to the company's employees, including senior management members. On the same date, the Board also resolved to grant a total of 8.055 million Restricted Share Units (RSUs) to 88 RSU recipients under the Post-IPO Restricted Share Award Scheme. Of the total 8.055 million RSUs granted, 4.27 million were allocated to one director, while 3.785 million were awarded to the company's employees, including members of the senior management team.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10